150 related articles for article (PubMed ID: 19475840)
1. [Dilated cardiomyopathy post-chemotherapy].
Sbrana F; Greco P; Rovai D
Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.
Hatake K; Miura Y
Lancet; 1996 May; 347(9013):1485. PubMed ID: 8676653
[No Abstract] [Full Text] [Related]
3. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
Katamadze NA; Lartsuliani KP; Kiknadze MP
Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
[TBL] [Abstract][Full Text] [Related]
4. [Anthracycline-induced cardiomyopathy].
Roul G; Cohen C; Lieber A
Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
[TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
Hadar A; Sheiner E; Press F; Katz A; Katz M
J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
[TBL] [Abstract][Full Text] [Related]
6. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
7. Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report.
Kuruc JC; Durant-Archibold AA; Motta J; Rao KS; Trachtenberg B; Ramos C; Wang H; Gorenstein D; Vannberg F; Jordan K
BMC Cardiovasc Disord; 2019 Jul; 19(1):169. PubMed ID: 31311496
[TBL] [Abstract][Full Text] [Related]
8. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
van den Berg MP; van Spaendonck-Zwarts KY; van Veldhuisen DJ; Gietema JA; Postma A; van Tintelen JP
Eur J Heart Fail; 2010 Dec; 12(12):1297-9. PubMed ID: 20952769
[No Abstract] [Full Text] [Related]
9. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
[TBL] [Abstract][Full Text] [Related]
10. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
[TBL] [Abstract][Full Text] [Related]
11. Regression of normalized left ventricular systolic function after discontinuation of treatment in patients with dilated cardiomyopathy.
Alahakoon PT; Binkley PF
Congest Heart Fail; 2009; 15(5):245-6. PubMed ID: 19751427
[No Abstract] [Full Text] [Related]
12. Left ventricular aneurysm in a patient with Duchenne muscular dystrophy.
Fayssoil A; Abdallah C; Orlikowski D
Presse Med; 2014 Jun; 43(6 Pt 1):731-2. PubMed ID: 24525307
[No Abstract] [Full Text] [Related]
13. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
14. [Possibilities of testosterone in complex therapy of patients with dilated cardiomyopathy].
Kurbanov RD; Abdullaev TA; Mardanov BU
Kardiologiia; 2009; 49(12):50. PubMed ID: 20038282
[No Abstract] [Full Text] [Related]
15. Dilated cardiomyopathy : clinical profile and treatment.
Khalil A; Chawla K; Chakravarti A
Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
[No Abstract] [Full Text] [Related]
16. Case of the month. Idiopathic dilated cardiomyopathy.
Parker T
JAAPA; 2009 Jul; 22(7):70. PubMed ID: 19697577
[No Abstract] [Full Text] [Related]
17. Reversible dilated cardiomyopathy in a patient with Cushing's syndrome.
Yong TY; Li JY
Congest Heart Fail; 2010; 16(2):77-9. PubMed ID: 20412474
[No Abstract] [Full Text] [Related]
18. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
[TBL] [Abstract][Full Text] [Related]
20. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
